Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904.
N Engl J Med. 2019.
PMID: 31091374
Clinical Trial.